Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fromm

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 10, 2006
Pharmacogenomics of human OATP transportersJörg König, Annick Seithel, Ulrike Gradhand, et al.
Clinical Pharmacology and Therapeutics|June 12, 2021
Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA StudyKatja Schlichtig, Pauline Dürr, Frank Dörje, et al.
Scientific Reports|July 8, 2017
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2BAnja Chafai, Martin F Fromm, Jörg König, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 30, 2010
Drug transport by breast cancer resistance proteinMaren Poguntke, Eszter Hazai, Martin F Fromm, et al.
Basic & Clinical Pharmacology & Toxicology|February 16, 2012
Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCPJörg König, Sabine Klatt, Karin Dilger, et al.
Diabetes|March 4, 2008
Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1Iouri Bachmakov, Hartmut Glaeser, Martin F Fromm, et al.
Plos One|March 14, 2019
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginineEmir Taghikhani, Renke Maas, Martin F Fromm, et al.
Pharmacological Reviews|March 1, 2018
Biomarkers for In Vivo Assessment of Transporter FunctionFabian Müller, Ashish Sharma, Jörg König, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 5, 2002
Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometryUte Hofmann, Monika Seiler, Siegfried Drescher, et al.
Deutsches Arzteblatt International|January 11, 2020
New Oral Anti-Cancer Drugs and Medication SafetyKatja Schlichtig, Pauline Dürr, Frank Dörje, et al.
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 10, 2006
Pharmacogenomics of human OATP transportersJörg König, Annick Seithel, Ulrike Gradhand, et al.
Clinical Pharmacology and Therapeutics|June 12, 2021
Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA StudyKatja Schlichtig, Pauline Dürr, Frank Dörje, et al.
Scientific Reports|July 8, 2017
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2BAnja Chafai, Martin F Fromm, Jörg König, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 30, 2010
Drug transport by breast cancer resistance proteinMaren Poguntke, Eszter Hazai, Martin F Fromm, et al.
Basic & Clinical Pharmacology & Toxicology|February 16, 2012
Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCPJörg König, Sabine Klatt, Karin Dilger, et al.
Diabetes|March 4, 2008
Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1Iouri Bachmakov, Hartmut Glaeser, Martin F Fromm, et al.
Plos One|March 14, 2019
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginineEmir Taghikhani, Renke Maas, Martin F Fromm, et al.
Pharmacological Reviews|March 1, 2018
Biomarkers for In Vivo Assessment of Transporter FunctionFabian Müller, Ashish Sharma, Jörg König, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 5, 2002
Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometryUte Hofmann, Monika Seiler, Siegfried Drescher, et al.
Deutsches Arzteblatt International|January 11, 2020
New Oral Anti-Cancer Drugs and Medication SafetyKatja Schlichtig, Pauline Dürr, Frank Dörje, et al.
Pageof 19